Successful treatment with nilotinib after bosutinib-induced pulmonary arterial hypertension recurrence following dasatinib in chronic myeloid leukemia in chronic phase

A 52-year-old man was diagnosed with chronic myeloid leukemia in the chronic phase (CML-CP). He experienced bosutinib-induced pulmonary arterial hypertension (PAH) recurrence following dasatinib use. Symptoms and examination findings associated with PAH improved after bosutinib cessation. Although n...

Descripción completa

Detalles Bibliográficos
Autores principales: Takatsuka, Ibuki, Hirata, Hiroya, Takahashi, Takumi, Dohtan, Satoshi, Oka, Shinichiro, Sakamoto, Nami, Takaba, Masamitsu, Adachi, Miwa, Takemura, Tomonari, Nagata, Yasuyuki, Ono, Takaaki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9059076/
https://www.ncbi.nlm.nih.gov/pubmed/35509967
http://dx.doi.org/10.1016/j.lrr.2022.100312

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9059076/
https://www.ncbi.nlm.nih.gov/pubmed/35509967
http://dx.doi.org/10.1016/j.lrr.2022.100312

Ejemplares similares